Healios Kk (4593) Press Release
FY2026 Q2 Financial Results (Material)
Earlier from Healios Kk
- Healios Selected for the AMED “Project to Promote the Industrialization of Regenerative/Cell Medicine and Gene Therapy”
- Notice Regarding the Filing of a Counterclaim in Response to a Lawsuit Filed Against Healios
- Healios K.K. to Present at Jefferies Global Healthcare Conference
- Healios K.K. to Present at Chardan’s 9th Annual Genetic Medicines Conference